228
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Development and validation of a revised instrument to measure burden of long-term medicines use: the Living with Medicines Questionnaire version 3

, &
Pages 155-168 | Published online: 28 May 2018

References

  • BarrettKLucasEAlexanderGCHow polypharmacy has become a medical burden worldwideClinical Pharmacist201686
  • GuthrieBMakubateBHernandez-SantiagoVDreischulteTThe rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010BMC Med20151311025563062
  • HeatonJBrittenNKrskaJReeveJPerson-centred medicines optimisation policy in England: an agenda for research on polypharmacyPrim Health Care Res Dev201718243427306579
  • TranV-TMontoriVMEtonDTBaruchDFalissardBRavaudPDevelopment and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditionsBMC Med2012106822762722
  • EtonDRidgewayJEggintonJFinalizing a measurement framework for the burden of treatment in complex patients with chronic conditionsPatient Relat Outcome Meas2015611712625848328
  • DuerdenMAveryTPayneRPolypharmacy and Medicines Optimisation – Making it Safe and SoundLondonThe King’s Fund2013
  • CooperJACadoganCAPattersonSMInterventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic reviewBMJ Open20155e009235
  • RyanRSantessoNLoweDInterventions to improve safe and effective medicines use by consumers: an overview of systematic reviewsCochrane Database Syst Rev20144CD007768
  • Royal Pharmaceutical SocietyMedicines optimisation: helping patients to make the most of medicines. Good practice guidance for healthcare professionals in England2013 Available from: http://www.rpharms.com/promoting-pharmacy-pdfs/helping-patients-make-the-most-of-their-medicines.pdfAccessed May 6, 2016
  • National Institute for Health and Care ExcellenceMedicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. NG52015 Available from: https://www.nice.org.uk/guidance/ng5Accessed February 10, 2017
  • BokhofBJunius-WalkerUReducing polypharmacy from the perspectives of general practitioners and older patients: a synthesis of qualitative studiesDrugs Aging20163324926626915076
  • MohammedMAMolesRJChenTFMedication-related burden and patients’ lived experience with medicine: a systematic review and metasynthesis of qualitative studiesBMJ Open20166116
  • EtonDTElraiyahTAYostKJA systematic review of patient-reported measures of burden of treatment in three chronic diseasesPatient Relat Outcome Meas2013472023833553
  • WillkeRJBurkeLBEricksonPMeasuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labelsControl Clin Trials20042553555215588741
  • KrskaJKatusiimeBCorlettSAValidation of an instrument to measure patients’ experiences of medicine use: the Living with Medicines QuestionnairePatient Prefer Adherence20171167167928405159
  • KatusiimeBCorlettSReeveJLKrskaJMeasuring medicines related experiences from the patient perspective: a systematic reviewPatient Relat Outcome Meas2016715717127785116
  • SchafheutleEIPatients’ views on the UK policy of prescription charges – insights from qualitative interviewsRes Social Adm Pharm2008434335419064241
  • Prescription Charges CoalitionPaying the price: prescription charges and people with long-term conditions2013 Available from: http://www.prescriptionchargescoalition.org.uk/uploads/1/2/7/5/12754304/paying_the_price_report.pdfAccessed March 2, 2017
  • The Prescription Charges CoalitionPaying the price: prescription charges and employment2014 Available from: http://www.prescrip-tionchargescoalition.org.uk/uploads/1/2/7/5/12754304/prescription_charges_and_employment_report_feb_2014.pdfAccessed September 21, 2015
  • KrskaJMorecroftCWPooleHRowePHIssues potentially affecting quality of life arising from long-term medicines use: a qualitative studyInt J Clin Pharm2013351161116923990332
  • PoundPBrittenNMorganMResisting medicines: a synthesis of qualitative studies of medicine takingSoc Sci Med20056113315515847968
  • BrittenNPatients’ ideas about medicines: a qualitative study in a general practice populationBr J Gen Pract1994444654687748635
  • BrittenNMedicines and Society: Patients, Professionals and the Dominance of PharmaceuticalsHampshire, NYPalgrave Macmillan2008
  • AnthoineEMoretLRegnaultASébilleVHardouinJ-BSample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measuresHealth Qual Life Outcomes20141217625492701
  • KahnJHFactor analysis in counseling psychology research, training, and practice principles, advances, and applicationsCouns Psychol200634684718
  • BeaversASLounsburyJWRichardsJKHuckSWSkolitsGJEsquivelSLPractical considerations for using exploratory factor analysis in educational researchPARE201318113
  • CostelloAOsborneJBest practices in exploratory factor analysis: four recommendations for getting the most from your analysisPARE20051019
  • ByrneBMStructural Equation Modeling with AMOS Basic Concepts, Applications, and Programming2nd edNew YorkTaylor and Francis Group LLC2010
  • KlineRBPrinciples and Practice of Structural Equation Modeling3rd edNew YorkThe Guilford Press2011
  • AtkinsonMJSinhaAHassSLValidation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseHealth Qual Life Outcomes200421214987333
  • AtkinsonMJKumarRCappelleriJCHassSLHierarchical Construct Validity of the Treatment Satisfaction Questionnaire for Medication (TSQM Version II) among outpatient pharmacy consumersValue Health20058S92416336491
  • HerdmanMGudexCLloydADevelopment and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Qual Life Res2011201727173621479777
  • JuniperEGuyattGJaeschkeRHow to develop and validate a new health-related quality of life instrumentSpilkerBQuality of Life and Pharmacoeconomics in Clinical TrialsNew YorkRaven Press19964956
  • TerweeCBBotSDMde BoerMRQuality criteria were proposed for measurement properties of health status questionnairesJ Clin Epidemiol200760344217161752
  • TabachnickBGFidellLSUsing Multivariate Statistics6th edBostonPearson Education2013
  • MokkinkLBTerweeCBPatrickDLThe COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi studyQual Life Res20101953954920169472
  • US Department of Health and Human Services Food and Drug AdministrationGuidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims2009 Available from: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory-Information/Guidances/UCM193282.pdfAccessed October 30, 2015
  • ZarowitzBJPolypharmacy: when is enough, enough?Geriatr Nurs20113244744922055638
  • CadoganCARyanCHughesCMAppropriate polypharmacy and medicine safety: when many is not too manyDrug Safety20163910911626692396
  • National Institute for Health and Care ExcellenceMultimorbidity: clinical assessment and managementNICE guideline [NG56]2016 Available from: https://www.nice.org.uk/guidance/ng56Accessed August 2, 2017
  • ZidanAAwaisuAHasanSKheirNThe Living with Medicines Questionnaire: translation and cultural adaptation into the Arabic contextValue Health Reg Issues201610364027881275